Advertisement

Loading...

Bangi Inc.

BNGIPNK
Healthcare
Biotechnology
$0.00
$-0.00(-90.00%)
U.S. Market is Open • 15:27

Bangi Inc. Fundamental Analysis

Bangi Inc. (BNGI) shows weak financial fundamentals with a PE ratio of -0.00, profit margin of 0.00%, and ROE of -3.10%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position37786.28%
PEG Ratio-0.00

Areas of Concern

ROE-3.10%
Operating Margin0.00%
Current Ratio0.44
We analyze BNGI's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -360.3/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-360.3/100

We analyze BNGI's fundamental strength across five key dimensions:

Efficiency Score

Weak

BNGI struggles to generate sufficient returns from assets.

ROA > 10%
-1.62%

Valuation Score

Excellent

BNGI trades at attractive valuation levels.

PE < 25
-0.00
PEG Ratio < 2
-0.00

Growth Score

Weak

BNGI faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

BNGI shows balanced financial health with some risks.

Debt/Equity < 1
0.04
Current Ratio > 1
0.44

Profitability Score

Weak

BNGI struggles to sustain strong margins.

ROE > 15%
-309.98%
Net Margin ≥ 15%
0.00%
Positive Free Cash Flow
No

Key Financial Metrics

Is BNGI Expensive or Cheap?

P/E Ratio

BNGI trades at -0.00 times earnings. This suggests potential undervaluation.

-0.00

PEG Ratio

When adjusting for growth, BNGI's PEG of -0.00 indicates potential undervaluation.

-0.00

Price to Book

The market values Bangi Inc. at 0.00 times its book value. This may indicate undervaluation.

0.00

EV/EBITDA

Enterprise value stands at -0.02 times EBITDA. This is generally considered low.

-0.02

How Well Does BNGI Make Money?

Net Profit Margin

For every $100 in sales, Bangi Inc. keeps $0.00 as profit after all expenses.

0.00%

Operating Margin

Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.

0.00%

ROE

Management delivers $-3.10 in profit for every $100 of shareholder equity.

-3.10%

ROA

Bangi Inc. generates $-1.62 in profit for every $100 in assets, demonstrating efficient asset deployment.

-1.62%

Following the Money - Real Cash Generation

FCF Per Share

Each share generates $-0.03 in free cash annually.

$-0.03

FCF Yield

BNGI converts -64.70% of its market value into free cash.

-64.70%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.00

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.00

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.00

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.04

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.44

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-3.10

vs 25 benchmark

ROA

Return on assets percentage

-1.62

vs 25 benchmark

ROCE

Return on capital employed

-4.62

vs 25 benchmark

How BNGI Stacks Against Its Sector Peers

MetricBNGI ValueSector AveragePerformance
P/E Ratio-0.0027.91 Better (Cheaper)
ROE-309.98%687.00% Weak
Net Margin0.00%-45285.00% (disorted) Weak
Debt/Equity0.040.33 Strong (Low Leverage)
Current Ratio0.442795.76 Weak Liquidity
ROA-162.14%-13557.00% (disorted) Weak

BNGI outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Bangi Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ